输送氧气的纳米颗粒增强了免疫疗法的有效性,在恶性瘤中通过酶B PET成像监测
Xingyi Wang1,2,3, Hanyi Fang4,5,6, Wenzhu Hu1,2,3
1Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Journal of nanobiotechnology
|March 6, 2025
概括
仿生纳米粒子为瘤提供氧气,减少缺氧并促进免疫治疗. 这种方法增强了免疫细胞活性和瘤抑制,通过PET成像监测治疗反应.
科学领域:
- 生物医学工程 生物医学工程
- 免疫治疗是一种免疫疗法.
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 免疫疗法的有效性受限于免疫细胞在低氧瘤微环境中的不良招募和激活.
- 瘤中的缺氧促进免疫抑制,阻碍了成功的癌症治疗.
- 有效监测免疫细胞活性对于评估免疫治疗反应至关重要.
研究的目的:
- 设计生物模拟氧气传递纳米粒子 (CmPF) 用于同类向和瘤中缺氧缓解.
- 调查CmPF在增强免疫细胞活性和免疫疗法的有效性方面的潜力.
- 建立一种非侵入性正子发射断层扫描 (PET) 成像方法,用于监测免疫细胞动态和治疗反应.
主要方法:
- 开发用于瘤微环境向设计的提供氧气的纳米粒子 (CmPF).
- 在瘤模型中,使用CmPF与碳烯和PD-1抑制剂进行组合治疗.
- 在体内监测免疫细胞活性,使用酶B向PET成像.
- 免疫组织化学分析以评估免疫标记物和瘤微环境重编程的变化.
主要成果:
- 与对照组相比,组合治疗显著抑制了瘤生长的2.4倍.
- CmPF有效地输送氧气,缓解瘤缺氧并促进免疫细胞活动.
- PET成像提供了对免疫细胞对治疗反应的动态实时评估.
- 免疫组织化学证实了关键免疫标记物的增强表达,表明瘤微环境的有利转变.
结论:
- 使用提供氧气的纳米颗粒来缓解缺氧是一种可行的策略,可以增强瘤免疫疗法.
- CmPF纳米颗粒在改善联合癌症治疗的疗效方面显示出显著的潜力.
- 针对Granzyme B的PET成像为免疫疗法反应的非侵入性监测提供了一个有价值的工具.
相关概念视频
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


